Atrioventricular (AV) Valves Summit 2023

Dr Guillaume Leurent is an interventional cardiologist at the University Hospital of Rennes, Rennes, FR. His scientific focus encompasses diverse cardiovascular pathologies, including myocardial infarction, sudden arrest, takotsubo syndrome, and postpartum cardiomyopathies. Dr Leurent's expertise spans coronary arteriography, angioplasty, cardiac MRI, and intensive care. He has published numerous original articles on these topics, contributing significantly to the field of cardiology. His holistic approach to patient care, coupled with his research contributions, establishes him as a respected figure in cardiovascular medicine, with a lasting impact on patient outcomes and medical advancements.

Prof Marta Sitges is a senior consultant non-invasive cardiologist at the Cardiovascular Institute in Hospital Clinic and Professor of Medicine at the University of Barcelona. She has also been the Director of the Cardiovascular Institute since October 2015.

Her main clinical practice is related to clinical and interventional echocardiography, sports cardiology and heart valve disease. She has an extensive publication track in these fields with participation in leading National and International meetings, she has received more than 60 peer reviewed grants and directed multiple MD and PhD thesis. 

Prof Maisano is Professor of Cardiac Surgery and Director of the Valve Center at San Raffaele Research Hospital in Milan.

Prof Maisano is a cardiac surgeon with large experience in standard cardiovascular treatments and innovative technologies, as well as cross-trained in interventional cardiology, with specific focus on structural interventions.

In his research, Prof Maisano was the principal investigator of the ACCESS EU Registry, the largest European registry monitoring the real-world results of MitraClip therapy. He is the co-inventor of a surgical annular prosthesis, which is now a standard surgical technique in the treatment of functional mitral valve regurgitation. 

Prof Maisano is an Editorial Board member of Cardiac Failure Review.

Prof Francesco Bedogni is the Director of the Clinical Cardiology, Interventional Cardiology, and Coronary Intensive Care Units (UTIC) at the IRCCS Policlinico San Donato, Milan, IT. He has authored over 320 scientific articles and abstracts, which have achieved significant bibliometric recognition. His contributions have appeared in prestigious journals such as Circulation, Journal of the American College of Cardiology, European Heart Journal, American Journal of Cardiology, QJM, Cardiology, Catheterisation and Cardiovascular Interventions, and Coronary Artery Disease.

Prof Francesco Bedogni serves as the Principal Investigator for numerous approval studies of CE and FDA-marked new devices in interventional cardiology.

He has participated as a Speaker and Moderator in 250 conferences both in Italy and abroad.

Dr Lluis Asmarats is an interventional cardiologist at Hospital de la Santa Creu i Sant Pau (Barcelona, ES) specialised in coronary and structural heart disease interventions. He served a fellowship in interventional and structural heart disease at the Quebec Heart and Lung Institute (Laval University, Quebec, CA), where he obtained his PhD in clinical medicine and biomedical sciences. His research interests focus on transcatheter therapies for structural heart disease.

Dr Tomás Benito González is an interventional cardiologist at the University Hospital of León, ES. His research interests are centred around ground-breaking areas such as percutaneous Mitral Valve Repair, percutaneous left atrial appendage closure, and the implications of Mitral Valve repair with Mitraclip, making significant contributions to the ongoing evolution of cardiac care.

Prof Ralph Stephan von Bardeleben is the Head of the Center of Structural Heart Disease Interventions and the Heart Valve Center in Mainz, Germany 

Prof Bardeleben is Past-President of the German working group on Echocardiography of the German Society of Cardiology and a member of several medical societies. He serves on the Clinical Program commission and at your region program of the ESC and is a reviewer for several peer-reviewed journals. Newly elected co-editor-in-chief of Echocardiography Journal.

He participates as PI, steering committee member and core laboratory in several medical device trials, including a German Federal Institute for Drugs and Medical Devices (BfArM)-approved first- or early-in-human medical device implant trials.